SQA Regulatory Surveillance Summary | Monthly Update 2022 – June
SQA
SEPTEMBER 2, 2022
United States Food and Drug Administration (FDA) – Regulations and Guidances. FDA Proposes Benefit-Risk Considerations for Product Quality Assessments, 20 June 2022. The FDA is announcing the availability of a draft guidance for industry entitled Conducting Remote Regulatory Assessments, Question and Answers.
91 
Let's personalize your content